Japan Diet Plans Changes To Speed Regenerative-Medicine Approvals
This article was originally published in PharmAsia News
Japan legislators plan to make some changes in a law passed earlier this year to regulate regenerative medicine to help speed the approval of products for the market.
You may also be interested in...
Amgen’s management took a deep dive into biosimilar market dynamics during the company’s third-quarter earnings call, as the California-based biotech continued to enjoy success for biosimilars in the US and Europe.
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
Russia seeks WHO endorsement of its Sputnik V vaccine, a UK BioIndustry Association task force identifies potential new antibody cocktails, and the European Centre for Disease Prevention and Control considers the best strategies for targeted vaccination programs.